• TRADE NAMES: Andro LA; Androderm (Actavis); AndroGel (AbbVie); Andronaq; Delatest; Delatestryl (Endo); Duratest; Fortesta (Endo); Natesto (Endo); Testandro; Testim (Auxilium); Testoderm; Testopel; Testopel
  • INDICATIONS: Androgen replacement; hypogonadism, postpartum breast pain
  • CLASS: Androgen
  • HALF-LIFE: 10–100 minutes
  • See adverse reactions attributed to class:

    Androgen

Contra-indicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate.

SECONDARY EXPOSURE TO TESTOSTERONE

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 10/01/2024

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric